OMOP Concept 4216788
Tumor finding
StandardConditionSNOMED395557000Clinical Finding
Maps from
2
Descendants
353
Valid from
31 Jan 2003
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
2 source codes normalize to Tumor finding via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| CIEL | 160590 | Primary tumor site | Non-standard |
| CIEL | 160591 | Primary tumor subsite | Non-standard |
Synonyms
Alternative names recorded for Tumor finding across source vocabularies.
- Tumor finding (finding)
- tumor - hallazgo
- tumor - hallazgo (hallazgo)
- Tumour finding
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(2)Roll up to these when you need a wider cohort.
Narrower concepts
(353)Included automatically when you query with descendants.
- 1Appendix with tumor involvement, with perforation not at tumor
- 1Basis of cancer diagnosis
- 1Complete obstructing tumor
- 1Distance of tumor from anal verge unknown
- 1Endocrine pancreas tumor finding
- 1Erosion of esophageal tumor into bronchus
- 1Erosion of esophageal tumor into trachea
- 1Excavated lesion of tumor
- 1Extent of tumor involvement not specified
- 1Extrascleral tumor extension present
- 1Flat tumor lesion
- 1Frond-like/villous tumor
- 1Fungating tumor
- 1International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index
- 1International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma (Schwannian stroma-poor), and low or intermediate mitosis-karyorrhexis index
- 1International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed (Schwannian stroma-rich)
- 1International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma (Schwannian stroma-dominant) maturing, or mature
- 1International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI
- 1International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
- 1International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index
- 1International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor)
- 1International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
- 1Intratumoral/peritumoral lymphocytic response absent
- 1Intratumoral/peritumoral lymphocytic response marked
- 1Intratumoral/peritumoral lymphocytic response mild to moderate
Showing 25 of 353. Retrieve the full set via the API.
Get this concept via the API
Resolve Tumor finding - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/4216788?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card